InvestorsHub Logo
Followers 2
Posts 71
Boards Moderated 0
Alias Born 02/29/2008

Re: None

Sunday, 02/19/2017 10:05:45 PM

Sunday, February 19, 2017 10:05:45 PM

Post# of 21531
Hey guys I know that am getting ahead of myself but I was looking at PSTI path for Early Marketing Approval which is very interesting. I have a question. AD fall under unmet medical need right? So, beside these path below. If data is good Is there any other path a drug can be approve for marketing while phase 3 is being run ? I mean, if we get data result like the three compassionate patient I know, I know long shot but, it could happen. Can phase 2 result be sufficient for Marketing Approval while conducting phase 3 ?

Priority Review
Breakthrough Therapy
Accelerated Approval?????
Fast Track
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News